[Federal Register Volume 60, Number 108 (Tuesday, June 6, 1995)]
[Notices]
[Page 29855]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-13710]



-----------------------------------------------------------------------



DEPARTMENT OF HEALTH AND HUMAN SERVICES

Statement of Organization, Functions, and Delegations of 
Authority

    Part H, Chapter HF (Food and Drug Administration) of the Statement 
of Organization, Functions, and Delegations of Authority for the 
Department of Health and Human Services (35 FR 3685, February 25, 1970 
and 56 FR 29484, June 27, 1991, as amended most recently in pertinent 
parts at 55 FR 12283, April 2, 1990) is amended to reflect the 
following reorganization in the Food and Drug Administration (FDA).
    The Office of Biotechnology, Office of Operations, is being 
abolished. The biotechnology industry has evolved to the point where 
the functions of this office are more appropriately performed by FDA's 
centers. The office's industry liaison activities will be performed by 
FDA's Office of External Affairs under its existing liaison functions.
    Under section HF-B, Organization:
    1. Delete subparagraph Office of Biotechnology (HFA-H), Office of 
Operations (HFA9), in its entirety.
    Prior Delegations of Authority. Pending further delegations, 
directives, or orders by the Commissioner of Food and Drugs, all 
delegations of authority to positions of the affected organizations in 
effect prior to this date shall continue in effect in them or their 
successors.

    Dated: May 17, 1995.
David A. Kessler,
Commissioner of Food and Drugs.
[FR Doc. 95-13710 Filed 6-5-95; 8:45 am]
BILLING CODE 4160-01-M